Most Popular
-
1
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
2
S. Korea not to attend Sado mine memorial: foreign ministry
-
3
First snow to fall in Seoul on Wednesday
-
4
Man convicted after binge eating to avoid military service
-
5
Wealthy parents ditch Korean passports to get kids into international school
-
6
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
-
7
[Weekender] Korea's traditional sauce culture gains global recognition
![[Weekender] Korea's traditional sauce culture gains global recognition](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050153_0.jpg&u=20241123224317)
-
8
BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
-
9
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
10
Nvidia CEO signals Samsung’s imminent shipment of AI chips
![[Weekender] Korea's traditional sauce culture gains global recognition](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050153_0.jpg&u=20241123224317)
S. Korean biotech firms eying phase 3 clinical trials of COVID-19 vaccines
By YonhapPublished : April 12, 2021 - 20:09
Five South Korean biotech companies are pushing for phase three clinical trials of COVID-19 vaccines in the second half of this year, the health ministry said Monday.
The government plans to inject about 68.7 billion won ($61 million) this year for the clinical trials of COVID-19 vaccines by SK Bioscience Co., EuBiologics Co., Cellid, Genexine and GeneOne Life Science, the ministry said.
The ministry made the announcement in a report to President Moon Jae-in.
Also Monday, the Ministry of Food and Drug Safety said it has received the application from South Korean biotech company GC Pharma for the approval of US biotech firm Moderna's COVID-19 vaccine.
In February, GC Pharma was selected as the company responsible for approval and distribution of Moderna's COVID-19 vaccine in South Korea.
In December, Moderna Chief Executive Stephane Bancel agreed to supply COVID-19 vaccine doses for 20 million people to South Korea during a videoconference with Moon. (Yonhap)
The government plans to inject about 68.7 billion won ($61 million) this year for the clinical trials of COVID-19 vaccines by SK Bioscience Co., EuBiologics Co., Cellid, Genexine and GeneOne Life Science, the ministry said.
The ministry made the announcement in a report to President Moon Jae-in.
Also Monday, the Ministry of Food and Drug Safety said it has received the application from South Korean biotech company GC Pharma for the approval of US biotech firm Moderna's COVID-19 vaccine.
In February, GC Pharma was selected as the company responsible for approval and distribution of Moderna's COVID-19 vaccine in South Korea.
In December, Moderna Chief Executive Stephane Bancel agreed to supply COVID-19 vaccine doses for 20 million people to South Korea during a videoconference with Moon. (Yonhap)
![[More than APT] Residents, architects together design homes](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/24/20241124050036_0.jpg&u=)
